|
How to defeat Surgical Site Infections
Brochure
|
pdf
(1.2 MB)
|
open
|
|
Impact of Adherence to bundle Strategy on Recution of AMR
ClinicalEvidence / Literature Review
|
pdf
(1.2 MB)
|
open
|
|
Management of Biofilm
World Union of Wound Healing Societies
|
pdf
(918.3 KB)
|
open
|
|
Prontosan Wound Gel X
|
pdf
(1.9 MB)
|
open
|
|
Prontosan Wound Gel, Prontosan Wound Gel X
|
pdf
(1.3 MB)
|
open
|
|
Prontosan breaks the Biofilm cycle_Flyer_3041_02.17
Flyer
|
pdf
(150.0 KB)
|
open
|
|
Prontosan® made easy
Wounds International
|
pdf
(293.0 KB)
|
open
|
|
Together against MDRO
Partner up with B. Braun to have the rightsolutions to fight Multi Drug Resistant Organisms as MRSA
|
pdf
(2.5 MB)
|
open
|
|
Prontosan® Wound Gel X
IFU
|
pdf
(1.1 MB)
|
open
|
|
Prontosan® Wound Gel X
Leaflet
|
pdf
(44.5 KB)
|
open
|
|
Prontosan® Wound Gel X
Leaflet
|
pdf
(162.5 KB)
|
open
|
|
Пронтосан
Leaflet
|
pdf
(91.1 KB)
|
open
|
|
Prontosan Wound Gel X
Safety Data Sheet (EU_en)
|
pdf
(197.0 KB)
|
open
|
|
Prontosan Wound Gel X
SDS
|
pdf
(193.7 KB)
|
open
|
|
About Antimicrobial Resistance (AMR)
Poster
|
pdf
(1.3 MB)
|
open
|
|
About MRSA_9007_01.19
|
pdf
(5.0 MB)
|
open
|
|
Prontosan Wound Gel, Wound Gel X_Flyer_3010_06.18
Flyer
|
pdf
(1.3 MB)
|
open
|
|
Prontosan breaks the Biofilm cycle_Poster_3038_02.17
Poster
|
pdf
(195.0 KB)
|
open
|
|
Prontosan Made Easy_05.11
|
pdf
(293.0 KB)
|
open
|
|
2021 Oropallo et al: Quality of life improvement in patients withhard-to-heal leg wounds
treated with Prontosan® Wound Irrigation Solution and Prontosan® WoundGel
|
pdf
(650.1 KB)
|
open
|
|
In Vitro Evaluation of Polihexanide, Octenidine and NaClO/HClO-BasedAntiseptics against Biofilm Formed by Wound Pathogens
Chronic wounds complicated with biofilm formed by pathogens remain one of the most significant challenges of contemporary medicine. The application of topical antiseptic solutions against wound biofilm has been gaining increasing interest among clinical practitioners and scientific researchers. This paper compares the activity of polyhexanide-, octenidine- and hypochlorite/hypochlorous acid-based antiseptics against biofilm formed by clinical strains of Candida albicans, Staphylococcus aureus and Pseudomonas aeruginosa. The analyses included both standard techniques utilizing polystyrene plates and self-designed biocellulose-based models in which a biofilm formed by pathogens was formed on an elastic, fibrinous surface covered with a fibroblast layer. The obtained results show high antibiofilm activity of polihexanide- and octenidine-based antiseptics and lack or weak antibiofilm activity of hypochlorite-based antiseptic of total chlorine content equal to 80 parts per million. The data presented in this paper indicate that polihexanide- or octenidine-based antiseptics are highly useful in the treatment of biofilm, while hypochlorite-based antiseptics with low chlorine content may be applied for wound rinsing but not when specific antibiofilm activity is required.
|
pdf
(2.7 MB)
|
open
|
